Back to search

Article

Niclosamide Prodrug Enhances Oral Bioavailability and Efficacy Against Hepatocellular Carcinoma by Targeting Vasorin-TGFβ Signaling

2025-03-05

Abstract excerpt

<h4>Background: </h4> Hepatocellular carcinoma (HCC) ranks third in cancer-related deaths worldwide, with limited therapeutic options. While niclosamide (NIC) has shown potential for repurposing in HCC, its poor water solubility and low bioavailability limit its efficacy, and its mechanisms of action are not yet fully elucidated. <h4>Methods:</h4> We designed a water-soluble NIC prodrug (NIC-PS) and evaluated its...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9c19cd7a-a731-55be-855f-2e00fbf3db20
DOI
10.22541/au.174119415.55528730/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Niclosamide Prodrug Enhances Oral Bioavailability and Efficacy Against Hepatocellular Carcinoma by Targeting Vasorin-TGFβ SignalingDOI 10.22541/au.174119415.55528730/v1
Select a neighboring publication to make it the new centre.